SCHEMBL21937573

SCHEMBL21937573

NCc1ccccc1C(=O)S

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FOLH1 Q04609 2/20 0.42
PNMT P11086 2/20 0.41
CA12 O43570 1/20 0.39
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA3 P07451 1/20 0.39
CA4 P22748 1/20 0.39
CA6 P23280 1/20 0.39
CA5A P35218 1/20 0.39
CA7 P43166 1/20 0.39
CA9 Q16790 1/20 0.39
CA13 Q8N1Q1 1/20 0.39
CA14 Q9ULX7 1/20 0.39
CA5B Q9Y2D0 1/20 0.39
HMGB1 P09429 1/20 0.39
DPP4 P27487 2/20 0.39
KDM4E B2RXH2 2/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALDH1A1 P00352 3/20 0.37
ALOX15 P16050 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3076314 0.82 PNMT (0.44) FOLH1PNMTHMGB1DPP4KDM4E
Hydrochloric Acid SCHEMBL8833438 0.80 PNMT (0.43) FOLH1PNMTHMGB1DPP4KDM4E
SCHEMBL6575704 0.80 GABRA1 (0.44) FOLH1CA12CA1CA2CA3
SCHEMBL136079 0.80 FOLH1 (0.59) FOLH1CA12CA1CA2CA4
Benzene SCHEMBL8597142 0.80 FOLH1 (0.59) FOLH1CA12CA1CA2CA4
SCHEMBL405123 0.80 KDM4E (0.52) PNMTHMGB1DPP4KDM4EALDH1A1
SCHEMBL11754063 0.80 HPGD (0.52) FOLH1CA12CA1CA2CA3
SCHEMBL21836661 0.78 FOLH1 (0.57) FOLH1CA12CA1CA2CA4
SCHEMBL10697636 0.78 PNMT (0.41) FOLH1PNMTHMGB1DPP4KDM4E
Hydrochloric Acid SCHEMBL20641021 0.78 FOLH1 (0.57) FOLH1CA12CA1CA2CA4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10626156-B2 Bioreversable promoieties for nitrogen-containing and hydroxyl-containing drugs Han, Jie (US) 2020-04-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10626156-B2 Bioreversable promoieties for nitrogen-containing and hydroxyl-containing drugs NOS2, EGLN2, HPGD FOLH1 221/4885PNMT 87/4885CA12 668/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.